Evidence map›Paper›PMID 28360103›Full record

ArticleThe Journal of biological chemistry2017

Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons.

Marthe H R Ludtmann, Charles Arber, Fernando Bartolome, Macarena de Vicente, Elisavet Preza, Eva Carro, Henry Houlden, Sonia Gandhi, Selina Wray, Andrey Y Abramov

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Targeting mitophagy in neurodegenerative diseases.Nature reviews. Drug discovery · 2025
    Review
  4. Article
  5. Review
  6. Energy substrate supplementation increases ATP levels and is protective to PD neurons.Current research in pharmacology and drug discovery · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. The role of iron homeostasis and iron-mediated ROS in cancer.American journal of cancer research · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Marthe H R LudtmannFrom the Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, United Kingdom.ORCID 0000-0003-1051-6425
Charles ArberFrom the Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, United Kingdom.
Fernando Bartolomethe Neurodegenerative Disorders Group, Research Institute Hospital 12 de Octubre (i+12), Madrid 28041, Spain.
Macarena de Vicentethe Neurodegenerative Disorders Group, Research Institute Hospital 12 de Octubre (i+12), Madrid 28041, Spain.
Elisavet PrezaFrom the Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, United Kingdom.ORCID 0000-0003-4082-4621
Eva Carrothe Neurodegenerative Disorders Group, Research Institute Hospital 12 de Octubre (i+12), Madrid 28041, Spain.ORCID 0000-0002-6504-4579
Henry Houldenthe Institute of Neurology, MRC Centre for Neuromuscular Diseases, London WC1N 3BG, United Kingdom.
Sonia Gandhithe Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, United Kingdom, and.ORCID 0000-0003-4395-2661
Selina WrayFrom the Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, United Kingdom.ORCID 0000-0003-3062-7050
Andrey Y AbramovFrom the Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, United Kingdom, a.abramov@ucl.ac.uk.ORCID 0000-0002-7646-7235
Institute of Structural and Molecular Biology · GBResearch Institute Hospital 12 de Octubre · ESNational Hospital for Neurology and Neurosurgery · GBSobell House · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Mutations in the gene encoding valosin-containing protein (VCP) lead to multisystem proteinopathies including frontotemporal dementia. We have previously shown that patient-derived

Indexed as

Adenosine TriphosphatasesCell Cycle ProteinsMutationAdenosine DiphosphateAdenosine TriphosphateBiological Transport, ActiveCell Line, TumorHumansInduced Pluripotent Stem CellsMitochondrial ADP, ATP TranslocasesMitochondrial MembranesNeurodegenerative DiseasesNeuronsProteostasis DeficienciesValosin Containing ProteinAdenosine DiphosphateAdenosine TriphosphatasesAdenosine TriphosphateCell Cycle ProteinsMitochondrial ADP, ATP TranslocasesValosin Containing ProteinVCP protein, humanADPamyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)ANTATPinduced pluripotent stem cell (iPS cell) (iPSC)mitochondriaVCP

Identifiers

PMID28360103
PMCPMC5448124
OpenAlexW2598685715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.